Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen

@article{Xu2010IdentificationOH,
  title={Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen},
  author={W. C. Xu and Hui-zhong Li and Jun-jie Liu and Zhen Guo and Bao-fu Zhang and Fei-fei Chen and Dong-Sheng Pei and Jun-nian Zheng},
  journal={Tumor Biology},
  year={2010},
  volume={32},
  pages={63-69}
}
Peptide-based immunotherapy strategies appear promising as an approach to successfully induce an antitumor immune response and prolong survival in patients with various cancers. Protein antigens and their specific epitopes are formulation targets for anti-tumor vaccines. Bioinformatical approaches to predict major histocompatibility complex binding peptides can facilitate the resource-consuming effort of T cell epitope identification. Proliferating cell nuclear antigen including Ki-67 and PCNA… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

realizing their potential

W ShreyaKanodia, Kast M. peptide-based vaccines for cancer
  • Expert Rev Vaccines. 2008;7:1533–45. Tumor Biol.
  • 2011
VIEW 1 EXCERPT

: a randomized , placebo controlled trial for dose optimization in 128 healthy subjects

GA Pietersz, DS Pouniotis, V Apostolopoalos
  • 2006